Thus, we further explored the SPOP genetic mutation in multiple cancers, the outcomes presented that the top 5 frequency of SPOP mutation existed in endometrial cancer, breast carcinoma, embryonal cancer, pancreatic cancer, and prostate cancer, those patients remained a poorer survival in mutated SPOP group. This evidence concerns the gene SPOP and familial pancreatic carcinoma.